Health Conditions

163 conditions with known genetic associations in our database.

Clear
All(163) Other(43,676) Cardiovascular(1,793) Metabolic(1,614) Renal(1,319) Cancer(1,257) Neurological(750) Ophthalmic(535) Gastrointestinal(367) Hematologic(345) Respiratory(323) Autoimmune(265) Dermatologic(221) Pharmacogenomic(163) Musculoskeletal(129)
Response to Simvastatin Treatment (pcsk9 Protein Level Change)
7 variants Pharmacogenomic
Cystatin C Levels in Top 1% of Individuals By Creatinine Levels
6 variants Pharmacogenomic
Disorders of Magnesium Metabolism (phecode 275.3)
6 variants Pharmacogenomic
Endostatin Levels
6 variants Pharmacogenomic
Follistatin Levels
6 variants Pharmacogenomic
Statin Intolerance or Statin-associated Muscle Symptoms
6 variants Pharmacogenomic
Statin-induced Myopathy (severe)
6 variants Pharmacogenomic
Statins
6 variants Pharmacogenomic
Arsenic Metabolism
5 variants Pharmacogenomic
Atorvastatin-induced Myalgia
5 variants Pharmacogenomic
Cystatin D Levels
5 variants Pharmacogenomic
Likely Inborn Error of Metabolism
5 variants Pharmacogenomic
Angiostatin Levels (plg.3710.49.2)
4 variants Pharmacogenomic
Brain Glucose Metabolism (fluorodeoxyglucose Uptake)
4 variants Pharmacogenomic
Caffeine Metabolism (plasma 1,3-dimethylxanthine (theophylline) Level)
4 variants Pharmacogenomic
Creatine Kinase Levels in Statin Users
4 variants Pharmacogenomic
Cystatin-8 Levels
4 variants Pharmacogenomic
Cystatin-b Levels
4 variants Pharmacogenomic
Cystatin-s Levels
4 variants Pharmacogenomic
Disorders of Carbohydrate Transport and Metabolism (phecode 271)
4 variants Pharmacogenomic
Disorders of Plasma Protein Metabolism (phecode 270.3)
4 variants Pharmacogenomic
Disorders of Protein Plasma/amino-acid Transport and Metabolism (phecode 270)
4 variants Pharmacogenomic
Histatin-3 Levels
4 variants Pharmacogenomic
Lactate Dehydrogenase Levels in Off-statin Users
4 variants Pharmacogenomic
Pharmacokinetics of Antiepileptic Drugs in Severe Mental Disorder (concentration Drug Ratio)
4 variants Pharmacogenomic
Pharmacokinetics of Olanzapine in Severe Mental Disorder (concentration Dose Ratio)
4 variants Pharmacogenomic
Somatostatin-28 Levels
4 variants Pharmacogenomic
Auc of 2-hydroxy Atorvastatin Lactone
3 variants Pharmacogenomic
Creatine Kinase Levels in Off-statin Users
3 variants Pharmacogenomic
Disorders of Calcium/phosphorus Metabolism (phecode 275.5)
3 variants Pharmacogenomic
Disorders of Mineral Metabolism (phecode 275)
3 variants Pharmacogenomic
Drug Metabolism
3 variants Pharmacogenomic
Follistatin-related Protein 1 Levels
3 variants Pharmacogenomic
Follistatin-related Protein 3 Levels
3 variants Pharmacogenomic
Follistatin-related Protein 4 Levels
3 variants Pharmacogenomic
Histatin-1 Levels
3 variants Pharmacogenomic
Kallistatin Levels (serpina4.3449.58.2)
3 variants Pharmacogenomic
Kininostatin Levels
3 variants Pharmacogenomic
Maximum Creatine Kinase Levels in Statin Users
3 variants Pharmacogenomic
Myocardial Infraction Risk Reduction in Statin Users
3 variants Pharmacogenomic
Oncostatin-m Levels (osm.2693.20.3)
3 variants Pharmacogenomic
Pharmacokinetics of Antipsychotic Drugs in Severe Mental Disorder (concentration Drug Ratio)
3 variants Pharmacogenomic
Treatment or Medication Use - Atorvastatin (ukb Data Field 20003_1141146234)
3 variants Pharmacogenomic
Auc of Atorvastatin
2 variants Pharmacogenomic
Caffeine Metabolism (plasma 1,7-dimethylxanthine (paraxanthine) Level)
2 variants Pharmacogenomic
Clopidogrel Response
2 variants Pharmacogenomic
Cystatin B Levels
2 variants Pharmacogenomic
Cystatin-8 Levels (cst8.10572.65.3)
2 variants Pharmacogenomic
Cystatin-m Levels
2 variants Pharmacogenomic
Disorders of Phosphorus Metabolism (phecode 275.53)
2 variants Pharmacogenomic
Endostatin Levels (col18a1.2201.17.6)
2 variants Pharmacogenomic
Estimated Glomerular Filtration Rate Based On Creatinine and Cystatin C in Top 1% of Individuals By Creatinine Levels
2 variants Pharmacogenomic
Etoposide Drug Response (ic50)
2 variants Pharmacogenomic
Histatin-1 Levels (htn1.10608.9.3)
2 variants Pharmacogenomic
Inborn Errors of Metabolism
2 variants Pharmacogenomic
Lactate Dehydrogenase Levels in Statin Users
2 variants Pharmacogenomic
Myostatin-related Muscle Hypertrophy
2 variants Pharmacogenomic
Oncostatin-m-specific Receptor Subunit Beta Levels
2 variants Pharmacogenomic
Rosuvastatin Response - Metabolism/pk
2 variants Pharmacogenomic
Statin-induced Myopathy
2 variants Pharmacogenomic
« Prev 1 2 3 Next »

Upload your DNA to discover which genetic variants you carry and assess your risk.

Get Started Free →